« More Trouble for Termeer if Left to Icahn | Main | Genzyme Pushes Back in Board Battle Royale »

05/06/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ed5eff49970b

Listed below are links to weblogs that reference PCV Testing Mini-Primer - GSK & Merck Rotavirus Contamination:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce Lehr

The FDA agrees, quite rightly in my view, that the risk/benefit equation stongly favors continued use of the GSK/Merck vaccines while PCV issues are studied further. I don't think 500,000 should miss their vaccines.
http://www.silobreaker.com/rotavirus-vaccines-benefits-outweigh-risks-fda-panel-says-5_2263433654950690860

Bruce Lehr

An update from the WSJ, the FDA has decided to allow both vaccines to stay on the market while the effects (if any) of the PCV1 are studied.
http://online.wsj.com/article/SB10001424052748703338004575230543979941932.html?mod=rss_Health

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada